The Use of a Viscous Cysteamine Eyedrop in a Belgian Cohort: Early 3-Year Results
Abstract Introduction With the life expectancy of patients with cystinosis increasing (ORPHA213), the corneal burden and the objective assessment of corneal crystal deposition have become increasingly important. Previous research highlights the disadvantages of hospital-prepared cysteamine solutions...
Saved in:
| Main Authors: | Emiel Matthys, Heleen Delbeke, Karel Van Keer, Ingele Casteels |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-06-01
|
| Series: | Ophthalmology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40123-025-01170-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cysteamine–bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis
by: Amer Jamalpoor, et al.
Published: (2021-06-01) -
Renal Transplantation in Patients with Cystinosis – A Case Series
by: Yashwanth Raj Thiagarajan, et al.
Published: (2024-12-01) -
Eyedrop Compliance and Literacy-Related Adherence Barriers After Cataract Surgery in Koforidua, Ghana
by: Devireddy N, et al.
Published: (2025-04-01) -
Clinical perspectives on myopathic complications in nephropathic cystinosis
by: Reza Sadjadi, et al.
Published: (2025-07-01) -
An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients
by: Goi N, et al.
Published: (2024-11-01)